Tag: pharmalittle

May 24, 2026

STAT+: Pharmalittle: We’re reading about a Parkinson’s drug setback, a Merck lung cancer therapy, and more

May 20, 2026

Biotech Investors Downplay Political Risk Amid FDA Inflection Point

April 7, 2026

FDA Proposes Domestic Drug Manufacturing Boost and TrumpRx Expands Drug List

April 1, 2026

FDA Considers Reversing Peptide Ban & Gene Editing Faces Hurdles

March 26, 2026

Novo Nordisk: Investor Concerns & Wegovy Price Cuts in South Africa

March 25, 2026

Merck $6.7B Terns Pharma Buy & Lilly’s Loxo Oncology Success

March 24, 2026

Trump Drug Pricing Plan Faces Scrutiny & Gilead’s $2.18B Acquisition of Ouro Medicines

March 23, 2026

Middle East Conflict & Lyme Vaccine: Pharma Supply Chains & New Hope

March 20, 2026

TrumpRx Reality Check & Wegovy High-Dose Approval: Healthcare Updates

March 19, 2026

Lilly’s Diabetes Drug Shows Weight Loss & TrumpRx Prices Questioned